Elderly travel frequencies and transport mode choices in Greater Rotterdam, the Netherlands

Demographic ageing is a key societal challenge in Europe as well as in many other western and non-western societies. A crucial dimension concerns elderly daily mobility patterns. While still partaking fewer and shorter trips than younger generations, today’s elderly have been found increasingly (auto)mobile. Although the elderly benefit from the independence, freedom of movement, and social inclusion, concerns may rise regarding the environmental and accessibility impacts of this induced mobility. The present study adds to the expanding literature on elderly mobility, an integrated analysis of the effects of socio-demographic, health, trip, spatial and weather attributes on elderly mobility. Utilizing travel diary data for Greater Rotterdam, The Netherlands, trip frequencies and transport mode choices of the elderly are analysed by means of zero-inflated negative binomial models as well as multinomial logit regression models, and contrasted to the non-elderly subpopulation to explore (dis)similarities. While the results show common determinants, the models also highlight important differences in the magnitude of the estimated coefficients and factors only influencing transport patterns for the elderly. Embedded in the context of an aging population, the empirical findings assist policy-makers and planners in several respects: For transportation plans and programs it is critical to recognize mobility needs of the elderly. As the seniors are becoming increasingly automobile, the results call for strategies to encourage older people to use more physically active and environmentally friendly transport modes such as public transport, walking and cycling

Oxytocin Reduces Background Anxiety in a Fear-Potentiated Startle Paradigm

Oxytocin reportedly decreases anxious feelings in humans and may therefore have therapeutic value for anxiety disorders, such as post-traumatic stress disorder (PTSD). As PTSD patients have exaggerated startle responses, a fear-potentiated startle paradigm in rats may have face validity as an animal model to examine the efficacy of oxytocin in treating these symptoms. Oxytocin (0, 0.01, 0.1, or 1.0 μg, subcutaneously) was given either 30 min before fear conditioning, immediately after fear conditioning, or 30 min before fear-potentiated startle testing to assess its effects on acquisition, consolidation, and expression of conditioned fear, respectively. Startle both in the presence and absence of the fear-conditioned light was significantly diminished by oxytocin when administered at acquisition, consolidation, or expression. There was no specific effect of oxytocin on light fear-potentiated startle. In an additional experiment, oxytocin had no effects on acoustic startle without previous fear conditioning. Further, in a context-conditioned test, previous light-shock fear conditioning did not increase acoustic startle during testing when the fear-conditioned light was not presented. The data suggest that oxytocin did not diminish cue-specific conditioned nor contextually conditioned fear, but reduced background anxiety. This suggests that oxytocin has unique effects of decreasing background anxiety without affecting learning and memory of a specific traumatic event. Oxytocin may have antianxiety properties that are particularly germane to the hypervigilance and exaggerated startle typically seen in PTSD patients